The effect of preoperative portal vein embolization on liver regeneration after extended hepatic resection

Hepato-Gastroenterology

Volumn 58, Issue 106, 2011, Pages 516-521

  Kim, Sung Hoon ^a   Kim, Im Kyung ^a   Hong, Young Ki ^b   Chol, Sae Byeol ^c   Lee, Kwang Hun ^a   Park, Seung Woo ^a   Kim, Kyung Sik ^a  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; BLEEDING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LIVER REGENERATION; LIVER RESECTION; LIVER WEIGHT; MALE; PORTAL VEIN; PORTAL VEIN EMBOLIZATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; ISCHEMIC PRECONDITIONING; LIVER REGENERATION; MALE; MIDDLE AGED; PORTAL VEIN; RETROSPECTIVE STUDIES;

EID: 79958132110     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999; 230:309-321. (Pubitemid 30191861)
2. Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, et al: Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Amer J Surg 1995; 169:28-35.
3. Burke EC, Jarnagin WR, Hochwald SN, Pisters PWT, Fong Y, Blumgart LH: Hilar cholangiocarcinoma: Patterns of spread, the importance of hepatic resection for curative operation, and a prosurgical clinical staging system. Ann Surg 1998; 228:385-394. (Pubitemid 30191701)
4. Neuhaus P, Jonas S, Bechstein WO, Lehmann R, Radke C, Kling N, et al: Extended resections for hilar cholangiocarcinoma. Annal Surg1999; 230:808-819.
5. Melendez J, Ferri E, Zwillman M, Fischer M, De-Matteo R, Leung D, et al: Extended hepatic resection: A 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg 2001; 192:47-53. (Pubitemid 32064097)
6. Vauthey JN, Baer HU, Guastella T, BIumgart LH: Comparison of outcome between extended and nonextended liver resections for neoplasms. Surgery 1993; 114:968-975. (Pubitemid 23336115)
7. Kinoshita H, Sakai K, Hirohashi K: Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986; 10:803-808. (Pubitemid 17197533)
8. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al: Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery 1990; 107:521-527. (Pubitemid 20156653)
9. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN: Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002; 137:675-681.
10. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, et al: Preoperative portal vein embolization for major liver resection: A meta-analysis. Ann Surg 2008; 247:49-57.
11. Katoh T, Tanaka M, Nimura Y, Kanai M, Nagino M, Ozawa T: Enhancement of rat liver mitochondrial function by portal branch ligation secures subsequent extended hepatectomy. Biochem Inter 1991; 24:107-116.
12. Mueller L, Broering DC, Meyer J, Vashist Y, Goettsche J, Wilms C, et al: The induction of the immediate-early-genes Egr-1, PAI-1 and PRL-1 during liver regeneration in surgical models is related to increased portal flow. J Hepatol 2002; 37:606-612. (Pubitemid 35305540)
13. Nagino M, Tanaka M, Nishikimi M, Nimura Y, Kubota H, Kanai M, et al: Stimulated rat liver mitochondrial biogenesis after partial hepatectomy. Cancer Res 1989; 49:4913-4918. (Pubitemid 19213647)
14. Takeuchi E, Nimura Y, Mizuno SI, Nagino M, Shoji-Kawaguchi M, Izuta S, et al: Ligation of portal vein branch induces DNA polymerases α, δ, and ε in nonligated lobes. J Surg Res 1996; 65:15-24. (Pubitemid 26339189)
15. Dindo D, Demartines N, Clavien PA: Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240:205-213. (Pubitemid 38963009)
16. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, et al: Standardized measurement of the future liver remnant prior to extended liver resection: Methodology and clinical associations. Surgery 2000; 127:512-519. (Pubitemid 30257509)
17. Altemeier WA, Gall EA, Zinninger MM, Hoxworth PI: Sclerosing carcinoma of the major intrahepatic bile ducts. AMA Arch Surg 1957; 75:450-460; discussion 60-1.
18. Klatskin G: Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38:241-256.
19. Rous P, Larimore LD: Relation of the Portal Blood to Liver Maintenance: A Demonstration of Liver Atrophy Conditional on Compensation. J Exp Med 1920; 31:609-632.
20. Lautt WW: Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 1985; 249.
21. Lautt WW, Legare DJ, D'Almeida MS: Adenosine as putative regulator of hepatic arterial flow (the buffer response). Am J Physiol - Heart Cir Physiol 1985; 17.
22. Koga M, Ogasawara H: Induction of hepatocyte mitosis in intact adult rat by interleukin-1α and interleukin-6. Life Sciences 1991; 49:1263-1270.
23. Feingold KR, Soued M, Grunfeld C, Moser AH, Verdier JA, DoVale HG: Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. Biochem Biophys Res Comm 1988; 153:576-582.
24. Nakamura T, Kitazawa T, Ichihara A: Partial purification and characterization of masking protein for B-type transforming growth factor from rat platelets. Biochem Biophys Res Comm 1986; 141:176-184. (Pubitemid 17002059)
25. Kokudo N, Kothary PC, Eckhauser FE, Raper SE: Transforming growth factor-α (TGF-α) improves hepatic DNA synthesis after hepatectomy in cirrhotic rats. J Surg Res 1992; 52:648-655.
26. Reinehr R, Häussinger D: Epidermal growth factor receptor signaling in liver cell proliferation and apoptosis. Biol Chem 2009; 390:1033-1037.
27. Kwang Choon L, Kinoshita H, Hirohashi K, Kubo S, Iwasa R: Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. W J Surg 1993; 17:109-115. (Pubitemid 23189031)
28. De Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM: Medical progress: Biliary tract cancers. New Eng J Med 1999; 341:1368-1378. (Pubitemid 29503577)
29. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al: Portal Vein Embolization before Right Hepatectomy: Prospective Clinical Trial. Ann Surg 2003; 237:208-217. (Pubitemid 38173248)
30. Hwang S, Lee SG, Ko GY, Kim BS, Sung KB, Kim MH, et al: Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg 2009; 249:608-616.
31. Gruttadauria S, Luca A, Mandata L, Miraglia R, Gridelli B: Sequential preoperative ipsilateral portal and arterial embolization in patients with colorectal liver metastases. World J Surg 2006; 30:576-578.
32. Nagino M, Kanai M, Morioka A, Yamamoto H, Kawabata Y, Hayakawa N, et al: Portal and arterial embolization before extensive liver resection in patients with markedly poor functional reserve. J Vas Interven Radiol 2000; 11:1063-1068.
33. Kyokane T, Nagino M, Oda K, Nimura Y: An experimental study of selective intrahepatic biliary ablation with ethanol. J Surg Res 2001; 96:188-196. (Pubitemid 34969432)
34. Schulte Am Esch Ii J, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, et al: Portal application of autologous CD133 bone marrow cells to the liver: A novel concept to support hepatic regeneration. Stem Cells 2005; 23:463-470. (Pubitemid 40478484)
35. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136. (Pubitemid 17174962)
36. Peralta C, Hotter G, Closa D, Prats N, Xaus C, Gelpí E, et al: The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A receptors. Hepatology 1999; 29:126-132. (Pubitemid 29023994)
37. Yadav SS, Sindram D, Perry DK, Clavien PA: Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 1999; 30:1223-1231. (Pubitemid 29510861)
38. Szijártó A, Hahn O, Lotz G, Schaff Z, Madarász E, Kupcsulik PK: Effect of ischemic preconditioning on rat liver microcirculation monitored with laser doppler flowmetry. J Surg Res 2006; 131:150-157. (Pubitemid 43227599)
39. Yin DP, Sankary HN, Chong ASF, Ma LLI, Shen J, Foster P, et al: Protective effect of ischemic preconditioning on liver preservation- reperfusion injury in rats. Transplantation 1998; 66:152-157. (Pubitemid 28369992)
40. Arai M, Tejima K, Ikeda H, Tomiya T, Yanase M, Inoue Y, et al: Ischemic preconditioning in liver pathophysiology. J Gastroenterol Hepatol 2007; 22.